 |
|
|
| |
Characterization of HBsAg Decline in the Tenofovir Disoproxil Fumarate and Peginterferon Alfa-2a Combination Study for Chronic Hepatitis B
|
| |
| |
Reported by Jules Levin
APASL 2015
March 12-15, Istanbul, Turkey
Henry L.Y. Chan1, Abdurrahman Kadayifci2, George Papatheodoridis3, Man-Fung Yuen4, Rong-Nan Chien5, W.C. Peter Kwan6, Lanjia Lin7, Phillip Dinh7, Eduardo B. Martins7, Prista Charuworn7, G. Mani Subramanian7, John G. McHutchison7, Joerg Petersen8, Mitchell Shiffman9, Hendrik W. Reesink10, Seng Gee Lim11, Young-Suk Lim12, Patrick Marcellin13
1Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong; 2University of Gaziantep, Gaziantep, Turkey; 3Athens University Medical School, "Laiko" General Hospital of Athens, Greece; 4Queen Mary Hospital, University of Hong Kong; 5Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Keelung, Taiwan; 6Gordon and Leslie Diamond Health Care Centre, University of British Columbia, Vancouver, BC, Canada; 7Gilead Sciences, Inc., Foster City, CA, USA; 8IFI Institute for Interdisciplinary Medicine at the Asklepios Klinik St. George, University of Hamburg, Hamburg, Germany; 9Liver Institute of Virginia, Bon Secours Health System, Richmond and Newport News, VA, USA; 10Academic Medical Center, Amsterdam, The Netherlands; 11Yong Loo Lin School of Medicine, National University of Singapore; 12Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; 13Hopital Beaujon, University of Paris, France
|
| |
|
|
|
|
|
